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Introduction
QUARTZ is the first phase III randomised clinical trial
of whole brain radiotherapy (WBRT) for patients with
inoperable brain metastases from non-small cell lung
cancer. It is designed as a non-inferiority trial to assess
whether WBRT may be omitted without detriment to
the patient’s survival while improving quality of life.
QUARTZ opened to recruitment in March 2007 and
currently has 76 UK and Australian centres open.
Despite universal support of the importance of the ques-
tion and a number of major initiatives aimed at improv-
ing recruitment, by mid-2010 recruitment was slower
than targeted and the trial was under threat of closure.
It was suggested that one of the reasons for investigators
not offering the trial to large numbers of their patients
and for patients rejecting randomisation, was the lack of
good quality preliminary randomised data to support
the trial question. Therefore it was proposed to make
the unusual step to release interim results from the trial
in order to provide investigators with further informa-
tion upon which to base trial decisions and discussions.
Methods
The Trial Management Group and Trial Steering Com-
mittee made the decision to release the interim results.
This decision was made without prior knowledge of the
results. Data on the first 151 patients were analysed, and
presented to investigators at a large meeting as part of a
detailed presentation, with emphasis on the limitations
of the data and guidance on interpretation. There are
plans to publish a formal paper of the results (and the
process) at a later date.
Results
The response from attendees at the meeting was very
positive. Attendees agreed that the results were not defi-
nitive in any way but provided a strong rationale for the
trial continuing, to answer this longstanding clinical
question. Recruitment has improved since the data
release, from an average of 7.3 patients per month in
July 2010, to an average of 10 patients per month by
August 2011.
Conclusions
There are dangers in releasing the interim results of a
trial. However in this non-inferiority trial, it was judged
that these dangers were outweighed by the dangers of
the trial closing because of poor accrual. Release of the
interim trial results in fact “saved” the trial from closure.
We shall present more general principals of when
release of interim trial results may be justified and
useful.
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